OPXA

11/14/2012 – Opexa Therapeutics Reports First Quarter 2012 Financial Results and Provides Corporate Update

[at noodls] – Opexa Therapeutics Reports Third Quarter 2012 Financial Results and Provides Corporate Update THE WOODLANDS, TX – (November 14, 2012) – Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tcelnaâ„¢, … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboard […]

11/13/2012 – Opexa Receives Clinical Trial Approval from Health Canada for Novel T-Cell Therapy

[at noodls] – Opexa Receives Clinical Trial Approval from Health Canada for Novel T-Cell Therapy Abili-T Clinical Trial Targeting Expansion to Canada; Non-proprietary Name Granted by USANC THE WOODLANDS, Texas – (November … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboard […]

11/05/2012 – Opexa Announces Agreements for up to $16.5 Million in Equity Commitments

[at noodls] – Opexa Announces Agreements for up to $16.5 Million in Equity Commitments Separate Purchase Agreements with Lincoln Park Capital Fund LLC May Provide Incremental Capital Availability thru mid 2015 THE WOODLANDS, … moreView todays social media effects on OPXAView the latest stocks trending across Twitter. Click to view dashboard […]